These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8461877)

  • 1. Investigation of two new [99mTc]Tc-HEDP preparations that can be expected to give a better lesion-to-normal-bone uptake ratio when used as bone scanning agents.
    de Ligny CL; Gelsema WJ; Hoevelaken TP; Schuring J
    Nucl Med Biol; 1993 Jan; 20(1):23-9. PubMed ID: 8461877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and biological distribution of technetium diphosphonate radiotracers synthesized without stannous ion.
    Deutsch E; Libson K; Becker CB; Francis MD; Tofe AJ; Ferguson DL; McCreary LD
    J Nucl Med; 1980 Sep; 21(9):859-66. PubMed ID: 6774066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The adsorption of 99mTc(Sn)-diphosphonate complexes on tri-calciumphosphate: the influence of preparation conditions, ligand-type, incubation media and adsorption conditions. The reversibility of the adsorption.
    Huigen YM; Krips HJ; Hulleman S; Gelsema WJ; De Ligny CL
    Int J Rad Appl Instrum A; 1990; 41(2):189-94. PubMed ID: 2158946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo distributions of some component fractions of Tc(NaBH4)-HEDP mixtures separated by anion exchange high performance liquid chromatography.
    Pinkerton TC; Ferguson DL; Deutsch E; Heineman WR; Libson K
    Int J Appl Radiat Isot; 1982 Oct; 33(10):907-15. PubMed ID: 6818160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative evaluation of three diphosphonates: in vitro adsorption (C- 14 labeled) and in vivo osteogenic uptake (Tc-99m complexed).
    Francis MD; Ferguson DL; Tofe AJ; Bevan JA; Michaels SE
    J Nucl Med; 1980 Dec; 21(12):1185-9. PubMed ID: 6449567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of the method of preparation of the bone scanning agent 99mTc(Sn)EHDP on its tissue distribution in the rat.
    Van den Brand JA; Das HA; Dekker BG; de Ligny CL; Van den Hamer CJ
    Int J Appl Radiat Isot; 1982 Oct; 33(10):917-28. PubMed ID: 6818161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of reaction conditions on preparations of rhenium-188 hydroxyethylidene diphosphonate complexes.
    Lin WY; Hsieh JF; Lin CP; Hsieh BT; Ting G; Wang SJ; Knapp FF
    Nucl Med Biol; 1999 May; 26(4):455-9. PubMed ID: 10382850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gel chromatographic analysis of the bone seeking radiopharmaceutical 99mTc(Sn)-EHDP: the influence of pH and EHDP-concentration on the size of its constituents.
    Huigen YM; Gelsema WJ; de Ligny CL
    Int J Rad Appl Instrum A; 1987; 38(8):615-8. PubMed ID: 2822619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 99mTc bone scanning agents--II. Adsorption of 99mTc(Sn)pyrophosphate complexes on the mineral phase of bone.
    Kroesbergen J; van Steijn AM; Gelsema WJ; de Ligny CL
    Int J Nucl Med Biol; 1986; 12(6):411-7. PubMed ID: 3011692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Technetium-99m complexes of dimethylaminomethylene diphosphonate (DMAD)--II. Biological distributions of 99mTc-DMAD components isolated by anion exchange HPLC.
    Holland ME; Bugaj J; Heineman WR; Deutsch E
    Int J Rad Appl Instrum B; 1989; 16(3):313-7. PubMed ID: 2497091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of DMSO treatment on the performance of [99mTc]HEDP.
    Bugaj JE; Esser PD; Tofe AJ; Borgia AT; Fawwaz RA
    Int J Nucl Med Biol; 1984; 11(2):109-11. PubMed ID: 6434460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastric uptake during Re-186 HEDP bone scintigraphy.
    Limouris GS; Skukla SK
    Anticancer Res; 1997; 17(3B):1779-81. PubMed ID: 9179234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of DMSO treatment on the composition of 99mTc(Sn)EHDP.
    de Groot GJ; Das HA; de Ligny CL
    Int J Rad Appl Instrum A; 1986; 37(6):487-90. PubMed ID: 3019948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A radiopharmaceutical and clinical comparison of 99mTc-Sn-hydroxymethylene diphosphonate with 99mTc-Sn-hydroxyethylidene diphosphonate.
    Silberstein EB
    Radiology; 1980 Sep; 136(3):747-51. PubMed ID: 6773104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 99mTc-labelled Cu(I)-EHDP, a potential skeletal imaging agent.
    Agha NH; Al-Hilli AM; Hassen HA
    Nuklearmedizin; 1981 Dec; 20(6):299-304. PubMed ID: 6799937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo behaviour of four different 99(m)Tc-HEDP complexes.
    Inoue O; Yamaguchi T; Ikeda I
    Nuklearmedizin; 1982 Dec; 21(6):227-31. PubMed ID: 6820139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of the bone-seeking agent 99mTc-1-hydroxyethylidene-1,1-diphosphonic acid to cartilage and collagen in vitro and its stimulation by Er3+ and low pH.
    Evans CH; Mears DC
    Calcif Tissue Int; 1980; 32(2):91-4. PubMed ID: 6773636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of formulation conditions on the distribution of 99mTc(NaBH4)-HEDP components separated by anion exchange HPLC.
    Zodda JP; Tanabe S; Heineman WR; Deutsch E
    Int J Rad Appl Instrum A; 1986; 37(4):345-54. PubMed ID: 3021657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone uptake studies in rabbits before and after high-dose treatment with 153Sm-EDTMP or 186Re-HEDP.
    Brenner W; Kampen WU; Brümmer C; von Forstner C; Zuhayra M; Czech N; Muhle C; Henze E
    J Nucl Med; 2003 Feb; 44(2):247-51. PubMed ID: 12571217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 186Re-HEDP: a potential therapeutic bone agent.
    Weininger J; Ketring AR; Deutsch EA
    Nuklearmedizin; 1984 Apr; 23(2):81-2. PubMed ID: 6433325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.